MedTrace Logo

The Effects of Lactobacillus Plantarum PS128 in Self-Reported Insomniacs

NCT04592276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-07-21

No results posted yet for this study

Summary

To determine whether PS128 (1) reduces the severity of anxiety and depressive symptoms, (2) adjusts autonomic nervous system functioning, and (3) improves sleep quality.

Conditions

Interventions

DIETARY_SUPPLEMENT

PS128

Participants took two capsules with PS128 after dinner for 30 days.

DIETARY_SUPPLEMENT

placebo

Participants took two capsules without PS128 after dinner for 30 days.

Sponsors & Collaborators

  • Bened Biomedical Co., Ltd.

    collaborator INDUSTRY

  • National Yang Ming Chiao Tung University

    lead OTHER

Principal Investigators

  • Cheryl C Yang, doctor · Institute of Brain Science ,National Yang-Ming University, Taipei City, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-11
Primary Completion
2019-12-27
Completion
2019-12-27

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592276 on ClinicalTrials.gov